Human hepatocyte morphology and functions in a multibore fiber bioreactor.

Institute on Membrane Technology, National Research Council of Italy, ITM-CNR, c/o University of Calabria, Via P. Bucci, cubo 17/C, Rende (CS), Italy.
Macromolecular Bioscience (Impact Factor: 3.74). 06/2007; 7(5):671-80. DOI: 10.1002/mabi.200600281
Source: PubMed

ABSTRACT The viability and liver specific functions of human hepatocytes in a multibore fiber bioreactor are reported. Human hepatocytes were cultured in the intraluminal compartment of the bioreactor. Human hepatocytes on the membranes maintained their round shape and showed focal adhesions as sites of interaction with the membrane surface. Cells in the bioreactor expressed liver specific functions, including synthetic and detoxification activity up to 14 d of culture. The results demonstrate that human hepatocytes cultured in the multibore fiber bioreactor are able to sustain the same in vivo liver functions in vitro.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The ideal bioartificial liver should be designed to reproduce as nearly as possible in vitro the habitat that hepatic cells find in vivo. In the present work, we investigated the in vitro perfusion condition with a view to improving the hepatic differentiation of pluripotent human liver stem cells (HLSCs) from adult liver. Tissue engineering strategies based on the cocultivation of HLSCs with hepatic stellate cells (ITO) and with several combinations of medium were applied to improve viability and differentiation. A mathematical model estimated the best flow rate for perfused cultures lasting up to 7 days. Morphological and functional assays were performed. Morphological analyses confirmed that a flow of perfusion medium (assured by the bioreactor system) enabled the in vitro organization of the cells into liver clusters even in the deeper levels of the sponge. Our results showed that, when cocultured with ITO using stem cell medium, HLSCs synthesized a large amount of albumin and the MTT test confirmed an improvement in cell proliferation. In conclusion, this study shows that our in vitro cell conditions promote the formation of clusters of HLSCs and enhance the functional differentiation into a mature hepatic population.
    Tissue Engineering Part C Methods 12/2010; 16(6):1543-51. · 4.64 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hollow fibre membrane bioreactors are ideal for tissue engineering applications because they can offer a large surface area to volume ratio in order to culture large numbers of cells in relatively small volumes of media. Poly(lactic-co-glycolic acid) (PLGA) hollow fibres have great potential for use in tissue engineering due to their biocompatibility and biodegradability, but their hydrophobicity results in low hydraulic permeability and limited cell adhesion. To overcome this, PLGA hollow fibres have been previously used immediately after fabrication, while still wet, or have been dried for storage and subsequently wetted with ethanol. These methods both present problems since the fibres cannot be stored wet as they degrade, while ethanol causes deformation such that they distort in the bioreactor and stick together. Here we present an alternative method to allow wetting of dried fibres by water alone: the addition of polyvinyl alcohol (PVA) to the spinning dope. Blending of PLGA and PVA resulted in a concentration-dependent increase of the mean pore size, porosity, contact angle, and a corresponding decrease in mechanical strength. To determine whether membranes were amenable to transport of culture medium and its constituents, permeation of water and a model protein, BSA, was assessed. No pure water or protein permeation was observed in PLGA hollow fibre membranes that had been dried for storage or PVA–PLGA blends with 1.25 and 2.5% PVA. However, fibres with 5% PVA that had been dried for storage allowed permeation of both water and BSA, without rejection of, or fouling by the protein. It was concluded that 5% PVA was sufficient to obtain wetting with water alone, and transport properties suitable for the permeation of media proteins without a significant or detrimental effect on mechanical strength. Therefore a PVA–PLGA blend by the addition of 5% (w/w) PVA to 20% (w/w) PLGA in N-methyl-2-pyrrolidone spinning dope is recommended when preparing PLGA hollow fibre membrane scaffolds.
    Journal of Membrane Science 11/2009; · 4.09 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The rapidly developing field of tissue engineering produces living substitutes that restore, maintain or improve the function of tissues or organs. In contrast to standard therapies, the engineered products become integrated within the patient, affording a potentially permanent and specific cure of the disease, injury or impairment. Despite the great progress in the field, development of clinically relevantly sized tissues with complex architecture remains a great challenge. This is mostly due to limitations of nutrient and oxygen delivery to the cells and limited availability of scaffolds that can mimic the complex tissue architecture. This study presents the development of a multilayer tissue construct by rolling pre-seeded electrospun sheets [(prepared from poly (l-lactic acid) (PLLA) seeded with C2C12 pre-myoblast cells)] around a porous multibore hollow fibre (HF) membrane and its testing using a bioreactor. Important elements of this study are: 1) the medium permeating through the porous walls of multibore HF acts as an additional source of nutrients and oxygen to the cells, which exerts low shear stress (controllable by trans membrane pressure); 2) application of dynamic perfusion through the HF lumen and around the 3D construct to achieve high cell proliferation and homogenous cell distribution across the layers, and 3) cell migration occurs within the multilayer construct (shown using pre-labeled C2C12 cells), illustrating the potential of using this concept for developing thick and more complex tissues. Copyright © 2012 John Wiley & Sons, Ltd.
    Journal of Tissue Engineering and Regenerative Medicine 04/2012; · 4.43 Impact Factor


Available from
May 31, 2014